In this study, the ALKBH5 protein was significantly downregulated in ccRCC (p < 0.001) and chRCC (p < 0.001) patients compared to controls, with no significant difference observed in pRCC patients. Here, ALKBH5 is linked to nonpapillary renal cell carcinoma.